Considering that fetuin-A and fetuin-B impact lipid accumulation and lipodegradation, and their altered expression in NAFLD, fetuin-A and fetuin-B are possibly involved in the regulation of renal and cardiovascular function in NAFLD. The gene discussed is AHSG; the disease is metabolic dysfunction-associated steatotic liver disease.